Psyence Biomedical Financials
| PBM Stock | USD 3.51 0.17 5.09% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 4.9 | 4.6625 |
|
| |||||
| Current Ratio | 0.0884 | 0.0931 |
|
|
The essential information of the day-to-day investment outlook for Psyence Biomedical includes many different criteria found on its balance sheet. An individual investor should monitor Psyence Biomedical's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Psyence Biomedical.
Net Income |
|
Psyence | Select Account or Indicator |
Understanding current and past Psyence Biomedical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Psyence Biomedical's financial statements are interrelated, with each one affecting the others. For example, an increase in Psyence Biomedical's assets may result in an increase in income on the income statement.
Psyence Biomedical Stock Summary
Psyence Biomedical competes with Cue Biopharma, Tff Pharmaceuticals, Eliem Therapeutics, Inhibrx, and Enliven Therapeutics. Pacific Booker Minerals Inc. engages in the exploration of mineral properties in Canada.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | G6448C103 74449F100 |
| Location | Ontario; Canada |
| Business Address | 121 Richmond Street |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.psyencebiomed.com |
| Phone | 416 346 7764 |
| Currency | USD - US Dollar |
Psyence Biomedical Key Financial Ratios
| EBITDA | (2.75 M) | ||||
| Net Income | (51.16 M) | ||||
| Cash Per Share | 0.02 X | ||||
| Current Ratio | 7.95 X | ||||
| Book Value Per Share | (0.82) X |
Psyence Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Psyence Biomedical's current stock value. Our valuation model uses many indicators to compare Psyence Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Psyence Biomedical competition to find correlations between indicators driving Psyence Biomedical's intrinsic value. More Info.Psyence Biomedical Ltd is rated below average in return on asset category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Psyence Biomedical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Psyence Biomedical Systematic Risk
Psyence Biomedical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Psyence Biomedical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Psyence Biomedical correlated with the market. If Beta is less than 0 Psyence Biomedical generally moves in the opposite direction as compared to the market. If Psyence Biomedical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Psyence Biomedical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Psyence Biomedical is generally in the same direction as the market. If Beta > 1 Psyence Biomedical moves generally in the same direction as, but more than the movement of the benchmark.
Psyence Biomedical November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Psyence Biomedical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Psyence Biomedical Ltd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Psyence Biomedical Ltd based on widely used predictive technical indicators. In general, we focus on analyzing Psyence Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Psyence Biomedical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.33) | |||
| Maximum Drawdown | 47.73 | |||
| Value At Risk | (18.55) | |||
| Potential Upside | 9.25 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.82) | Return On Assets (1.26) |
The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.